SCHEMBL669797

SCHEMBL669797

CC1CCCCCC1(C)C1CCCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 1/20 0.38
ATP1A1 P05023 1/20 0.34
ATP1B1 P05026 1/20 0.34
ATP1A3 P13637 1/20 0.34
ATP1B2 P14415 1/20 0.34
ATP1A2 P50993 1/20 0.34
ATP1B3 P54709 1/20 0.34
FXYD2 P54710 1/20 0.34
ATP1A4 Q13733 1/20 0.34
AKR1B10 O60218 1/20 0.30
AKR1B1 P15121 1/20 0.30
EFNA1 P20827 1/20 0.30
EPHA2 P29317 1/20 0.30
PSEN1 P49768 1/20 0.30
PSEN2 P49810 1/20 0.30
GPBAR1 Q8TDU6 1/20 0.30
APH1B Q8WW43 1/20 0.30
NCSTN Q92542 1/20 0.30
APH1A Q96BI3 1/20 0.30
PSENEN Q9NZ42 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6537000 1.00 CYP19A1 (0.38) CYP19A1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL11349571 1.00 CYP19A1 (0.38) CYP19A1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL27732284 1.00 CYP19A1 (0.38) CYP19A1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL16029934 1.00 CYP19A1 (0.38) CYP19A1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL11051376 0.93 CYP19A1 (0.35) CYP19A1ATP1A1ATP1B1ATP1A3ATP1B2
Ammonia Solution, Strong SCHEMBL28234423 0.88 CYP19A1 (0.33) CYP19A1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL8848387 0.88 CYP19A1 (0.32) CYP19A1
SCHEMBL27994797 0.84 CYP3A4 (0.35) CYP19A1ATP1A1ATP1B1ATP1A3ATP1B2
SCHEMBL6891271 0.83 CYP19A1 (0.35) CYP19A1ATP1A1ATP1B1ATP1A3ATP1B2
Methacrylic Acid SCHEMBL6537143 0.82 GPBAR1 (0.34) CYP19A1ATP1A1ATP1B1ATP1A3ATP1B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113025241-B Adhesive composition and adhesive film 藤森工业株式会社 2024-06-28 CN disclosed
WO-2024045134-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2024-03-07 WO disclosed
WO-2024045134-A1 ORGANIC COMPOUNDS GIVAUDAN SA (CH) 2024-03-07 WO disclosed
WO-2024047093-A1 DIMETHYLBICYCLOHEPTENYL AND DIMETHYLBICYCLOHEPTANYL DERIVATIVES AND THEIR USE AS ODORANTS GIVAUDAN SA (CH) 2024-03-07 WO disclosed
WO-2024047093-A1 DIMETHYLBICYCLOHEPTENYL AND DIMETHYLBICYCLOHEPTANYL DERIVATIVES AND THEIR USE AS ODORANTS GIVAUDAN SA (CH) 2024-03-07 WO disclosed
CN-111849361-B Adhesive composition for optical use, and adhesive film and adhesive sheet each using the same 藤森工业株式会社 2024-01-12 CN disclosed
CN-106047230-B Adhesive layer and adhesive film 藤森工业株式会社 2023-08-08 CN disclosed
CN-113025241-A Adhesive composition and adhesive film 藤森工业株式会社 2021-06-25 CN disclosed
CN-111849361-A Optical adhesive composition, and adhesive film and adhesive sheet using same 藤森工业株式会社 2020-10-30 CN disclosed
CN-106118554-B Adhesive layer and adhesive film 藤森工业株式会社 2020-09-29 CN disclosed
EP-2782645-A2 USE OF ISOSORBIDE CAPRYLATES/CAPRATES IN DEODORANTS AND ANTIPERSPIRANTS Clariant Finance (BVI) Limited (VG) 2014-10-01 EP disclosed
US-8742110-B2 Spiroxazolidinone compounds MERCK SHARP & DOHME CORP. (US) 2014-06-03 US disclosed
EP-2605658-A1 SPIROXAZOLIDINONE COMPOUNDS Merck Sharp & Dohme Corp. (US) 2013-06-26 EP disclosed
WO-2013075826-A2 USE OF ISOSORBIDE CAPRYLATES/CAPRATES IN DEODORANTS AND ANTIPERSPIRANTS CLARIANT INTERNATIONAL LTD (CH) 2013-05-30 WO disclosed
US-20130131042-A1 SPIROXAZOLIDINONE COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2013-05-23 US disclosed
WO-2012024183-A1 SPIROXAZOLIDINONE COMPOUNDS MERCK SHARP & DOHME CORP. (US) 2012-02-23 WO disclosed
US-20060198973-A1 Packaging with cycloolefin food/beverage contact layer TOPAS ADVANCED POLYMERS, INC. 2006-09-07 US disclosed
US-4271046-A Novel norcamphanyl-substituted pyrans, method for their synthesis and use thereof in perfumery FRITZSCHE DODGE & OLCOTT, INC. (US) 1981-06-02 US disclosed
WO-1980000839-A1 NOVEL NORCAMPHANYL-SUBSTITUTED PYRANS,METHOD FOR THEIR SYNTHESIS AND USE THEREOF IN PERFUMERY FRITZSCHE DODGE & OLCOTT INC (US) 1980-05-01 WO disclosed
US-4197246-A Novel norcamphanyl-substituted pyrans, method for their synthesis and use thereof in perfumery FRITZSCHE DODGE & OLCOTT, INC. (US) 1980-04-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130131042-A1 SPIROXAZOLIDINONE COMPOUNDS SSTR5, SSTR2, SSTR4 CYP19A1 589/4885ATP1A1 2939/4885ATP1B1 3474/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.